Technical Analysis for ZVSA - ZyVersa Therapeutics, Inc.

Grade Last Price % Change Price Change
F 1.14 -0.87% -0.01
ZVSA closed down 6.5 percent on Wednesday, November 20, 2024, on 1.72 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction -0.87%
Wide Bands Range Expansion -0.87%
Gapped Down Weakness -0.87%
Oversold Stochastic Weakness -0.87%
NR7 Range Contraction -7.32%
Narrow Range Bar Range Contraction -7.32%
Wide Bands Range Expansion -7.32%
Oversold Stochastic Weakness -7.32%
Slingshot Bearish Bearish Swing Setup -8.06%
Stochastic Buy Signal Bullish -8.06%

   Recent Intraday Alerts

Alert Time
Down 3% about 3 hours ago
Down 2 % about 3 hours ago
Down 1% about 3 hours ago
Up 1% about 3 hours ago
2x Volume Pace 1 day ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

ZyVersa is a clinical stage specialty biopharmaceutical company leveraging advanced, proprietary technologies to develop product candidates that address high unmet medical needs in the areas of renal and inflammatory diseases. ZyVersa's development pipeline includes phase 2a ready VAR 200, a cholesterol efflux mediator for treatment of rare kidney disease, focal segmental glomerulosclerosis. ZyVersa believes VAR 200 has potential to treat other glomerular diseases, including Alport syndrome and diabetic kidney disease. ZyVersa's development pipeline also includes IC 100, a novel inflammasome ASC inhibitor being developed to treat a multitude of inflammatory diseases.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Organ Systems Kidney Disease Inflammatory Diseases Kidney Diabetic Nephropathy Alport Syndrome Diabetic Kidney Disease Focal Segmental Glomerulosclerosis Glomerulosclerosis Inflammasome Stage Specialty Biopharmaceutical

Is ZVSA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 42.385
52 Week Low 1.05
Average Volume 1,552,477
200-Day Moving Average 4.49
50-Day Moving Average 2.03
20-Day Moving Average 1.63
10-Day Moving Average 1.26
Average True Range 0.24
RSI (14) 32.43
ADX 19.81
+DI 25.32
-DI 32.25
Chandelier Exit (Long, 3 ATRs) 2.65
Chandelier Exit (Short, 3 ATRs) 1.77
Upper Bollinger Bands 2.48
Lower Bollinger Band 0.79
Percent B (%b) 0.21
BandWidth 103.60
MACD Line -0.29
MACD Signal Line -0.26
MACD Histogram -0.0329
Fundamentals Value
Market Cap 1.89 Million
Num Shares 1.64 Million
EPS -78.43
Price-to-Earnings (P/E) Ratio -0.01
Price-to-Sales 0.00
Price-to-Book 0.05
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.29
Resistance 3 (R3) 1.28 1.24 1.26
Resistance 2 (R2) 1.24 1.20 1.24 1.25
Resistance 1 (R1) 1.19 1.18 1.22 1.20 1.25
Pivot Point 1.15 1.15 1.16 1.15 1.15
Support 1 (S1) 1.10 1.11 1.13 1.11 1.05
Support 2 (S2) 1.06 1.09 1.06 1.05
Support 3 (S3) 1.01 1.06 1.04
Support 4 (S4) 1.02